Recent Advances in AI-enabled Automated Medical Diagnosis (PDF)

Dr Wei's research interests include nonlinear system identification, machine learning, neural networks, interpretable machine learning, deep learning, computational intelligence, AI and its applications, data-driven modelling, data mining, pattern recognition, data based and data informed predictive modelling, with applications in medical research and AI-assisted diagnosis among other areas.

Danny Crookes is an Emeritus Professor at Queen's University Belfast (QUB), where was earlier the Head of the computer science department from 1993 to 2002 and was also appointed to the Chair of the Computer Engineering. He was also the Director of the Research for Speech, Image, and Vision Systems at the Institute for Electronics, Communications, and Information Technology (ECIT), QUB before he retired, in 2017. He is currently an Emeritus Professor in computer science with QUB. He has published more than 200 scientific articles in journals and international conferences, and has presented tutorials on parallel image processing at several international conferences. His current research interests include the use of novel architectures (especially GPUs) for high-performance image processing.

Professor Crookes has applied expertise in language design, optimizing compilers and software generators, plus software tools for hardware description, and architecture generation, to the goal of developing high level software tools to enable rapid development of real-time video processing systems. He has been currently involved in projects in automatic shoeprint recognition (ESPRC), speech separation and enhancement (EPSRC), and processing of 4D confocal microscopy imagery (sponsored by INI and Andor Technologies).

Paul Chazot is an Associate Professor of Neuropharmacology in Biosciences, Durham University. He is leading a research group focusing on the identification, characterisation and validation of novel drug targets for the treatment of the major acute and chronic CNS pathologies. He also dedicates to developing novel all-in-one behavioural tests for both animals and humans. Dr Chazot has developed two new clinical development programmes over the last 20 years, one for chronic pain (Votucalis), and one for Alzheimer's Disease (PBM-T 1068nm), the former at the pipeline stage for the company Akari Therapeutics UK, and the latter reaching the FDA Phase 2b clinical stage in the US. He is also the Durham lead for the Durham University spin-out company Nevrargenics, who has developed exciting new rational drug leads (RAR-M) for disease-modifying in a range of neurodegenerative diseases.

Dr Chazot is the Past President of European Histamine Research Society, Fellow of British Pharmacological Society, Chair of an International Union of Pharmacological Societies subcommittee, President of Parkinson's UK Durham Branch, member of Newcastle ARUK funding committee, and Director of the Durham Wolfson Research Institute of Health and Wellbeing Pain Special Interest Group (Northern Pain Alliance) & Enlighten Delirium (recently secured an Innovate UK health device grant), since 2012.